European Healthcare Alliance

What European Healthcare Alliance does

European Healthcare Alliance (EHA) is a membership-based organization operating a members-only digital platform that connects EU healthcare companies and consultants for business development, out-licensing, in-licensing, and cross-border partnership activity. Founded in January 2026 by Nemysis Limited (Ireland), Enteralia Bioscience S.r.l. (Italy), and Ricerchimica S.r.l. (Italy), and headquartered at Via Turati 29 in Milan, the alliance covers pharmaceuticals, medical devices, food supplements, cosmetics, and related intellectual property. Its core product, the EHA Digital Platform at eha-network.com, launched on 25 March 2026 and provides a searchable members database, therapeutic-area and target-country filters, opportunity listings for licensing assets, and tailored alerts; a coordinated non-EU scouting service complements the platform by sourcing innovative products for European commercialization.

The business model is subscription-based and gate-kept: prospective members submit applications reviewed by EHA and approved by existing members, with annual subscription fees that vary by applicant type (commercial companies versus R&D and service organizations). Fee amounts are not publicly disclosed; membership is valid for 12 months from profile activation. Go-to-market combines the website and platform, LinkedIn, European-level industry events and trade fairs, referrals from existing members, and earned media via press releases. Customer segments span pharmaceutical companies (primary), biotechnology companies, medical technology companies, specialized consultancies and institutions, and non-EU healthcare companies seeking market entry into Europe.

The operating model is intentionally lean — 1–10 employees, with a leadership team drawn from pharma BD and licensing backgrounds (Fidia Pharmaceuticals USA, Madaus AG, Plexus Ventures, EY), and operates without external institutional investment. EHA monetizes the trust and curation embedded in its closed network rather than running an open marketplace, and positions its value proposition around reduced BD friction, accelerated deal cycles, and shared non-EU scouting intelligence that would be materially more expensive for any single member to replicate.

Name

European Healthcare Alliance

Legal name

European Healthcare Alliance

Website

https://eha-network.com

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

1–10 employees

Short description

European Healthcare Alliance operates a members-only digital platform connecting EU healthcare companies and consultants for licensing, partnership, and cross-border business development activities across pharmaceuticals, medical devices, food supplements, and cosmetics.

Ownership category

akta.pro rank

Headquarters

HQ city

Milano

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Membership Subscriptions: EHA operates as a membership-based organization. Subscription fees vary depending on whether the applicant is a commercial company or an R&D and service organisation. Membership is valid for 12 months from the date the company profile is activated.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

European Healthcare Alliance operates a members-only digital platform that enables European healthcare companies to showcase assets available for licensing, access qualified business opportunities shared by other members, and identify potential partners through intuitive search tools. The alliance also provides structured scouting activities focused on identifying innovative non-EU healthcare products and supporting their entry into European markets, plus a curated network database with tailored opportunity alerts based on therapeutic areas and target countries.

Product overview

European Healthcare Alliance (EHA) operates as a membership-based alliance platform for EU healthcare companies, consisting of a digital platform and coordinated services. The core EHA Digital Platform enables members to showcase licensing opportunities, access qualified business opportunities, and identify partners through search tools. Supporting services include structured scouting activities for non-EU product identification and a members-only database with tailored opportunity alerts. Founded in 2026 by Nemysis Ltd., Enteralia Bioscience S.r.l., and Ricerchimica S.r.l., the alliance covers pharmaceuticals, medical devices, food supplements, cosmetics, and related intellectual property.

Differentiator

Problem solved

Functional benefit

Products and services

• EHA Digital Platform A members-only digital platform connecting companies and consultants across the European healthcare sector, enabling members to showcase assets available for licensing, access qualified opportunities from other members, and identify potential partners through intuitive search tools. Targeted at pharmaceutical, medical device, food supplement, cosmetic, and related intellectual property companies.
• Structured Scouting Activity
• Members-Only Network Database A curated searchable database where members can list their products and services to increase visibility within the network, with tailored alerts on relevant opportunities based on selected therapeutic areas and target countries.

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered core.

• Nemysis LimitedcoreStrategic or Co-development Partner · 1 January 2026Nemysis Limited is a founding member of EHA. The company is a fully integrated biopharmaceutical company that participates in EHA given its innovative approach to simplifying business development. The exchange of information on available products provides new opportunities to expand portfolios and strengthen collaborations with existing commercial partners.
• Enteralia Bioscience S.r.l.coreStrategic or Co-development Partner · 1 January 2026Enteralia Bioscience S.r.l., part of the Nemysis Limited Group, is an Italian pharmaceutical company and founding member of EHA. Founded in 2025, it focuses on gynecology and gastroenterology therapeutic areas and expanding direct commercial activities for the Group's product portfolio.
• Ricerchimica S.r.l.coreStrategic or Co-development Partner · 1 January 2026Ricerchimica S.r.l. is a founding member of EHA. Founded in 1973, the company is a Life Sciences consulting firm specializing in M&A and transaction services, including licensing, asset acquisition and divestment, and business development support. EHA aligns with their core activities in M&A and licensing advisory within Life Sciences.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Others

• L.E.K. Consulting: Global management consulting firm with a dedicated healthcare and life sciences practice serving pharma and medtech clients on strategy and corporate development. Comparable as an external advisor competing for the same pharma BD budget that funds EHA memberships.
• EY-Parthenon Life Sciences: Global professional services firm with a dedicated Life Sciences practice advising on licensing, M&A, and corporate development. Comparable as a provider of pharma BD advisory services at much larger scale; EHA founding team member previously served as Senior Advisor to EY.

Broad incumbents

• MedTech Europe: The European trade association representing the medical technology industry. Comparable to EHA as an industry membership organization serving healthcare companies, with overlapping medical device segment coverage.
• BIO (Biotechnology Innovation Organization): World's largest biotechnology trade association offering member networking, partnering events, and business development services. Comparable as an industry membership organization for biotech and healthcare companies, with a major EU presence via BIO-Europe.
• CPHI (Informa Markets): Operates the world's largest pharma networking events and online directories connecting suppliers and buyers across the pharmaceutical value chain. Comparable to EHA as a pharma networking and BD platform, though more transactional and event-driven.
• EFPIA: The European Federation of Pharmaceutical Industries and Associations, the leading EU pharma trade association. Comparable to EHA as a membership-based industry alliance serving European healthcare companies, though broader in advocacy scope.
• EuropaBio: The European bio-industry association representing biotech companies and national associations. Comparable to EHA as a membership-based alliance serving healthcare companies across Europe, though focused on biotech advocacy and policy.

Direct peers

• PharmaVentures: Specialist pharma licensing, M&A, and business development advisory firm connecting pharmaceutical companies for deal-making. Comparable to EHA in serving as a focused intermediary in pharma licensing partnerships.
• Plexus Ventures: Specialized life sciences licensing and M&A advisory firm. Directly comparable to EHA in facilitating pharma licensing deals, with additional overlap via EHA's founding team member who previously served as Director for Southern Europe at Plexus Ventures.
• EBD Group (Informa Connect): Operates the BIO-Europe partnering platform and related pharma/biotech licensing events with digital matchmaking tools. Direct competitor to EHA in facilitating cross-border pharmaceutical business development and licensing partnerships.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/european-healthcare-alliance

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Healthcare Alliance